• Indian Indices
  • Global Indices
  • Commodities
  • Currency
Sensex
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
{{x.upd_time}}
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
  • HANG SENG
{{x.Date}}
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
Gold
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
USDINR
  • USDINR
  • GBPINR
  • EURINR
  • JPYINR
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 26-Nov-2021 EOD, Market Closed
SENSEX
57,107.15
-1,687.94 (-2.87%)
NIFTY
17,026.45
-509.80 (-2.91%)
    No Companies Visited

Back to news list
  • Lupin reports Q2 loss at Rs 2098 cr

    The drug maker reported a consolidated net loss of Rs 2098.04 crore in Q2 September 2021 as against net profit of Rs 211.02 crore in Q2 September 2020.

    On a consolidated basis, net sales rose 5.86% to Rs 4003.42 crore in Q2 September 2021 over Q2 September 2020. Pre-tax loss stood at Rs 2204.78 crore in Q2 September 2021 as against pre-tax profit of Rs 360.21 crore in Q2 September 2020.

    EBITDA rose 3.7% to Rs 628.50 crore in Q2 September 2021 over Q2 September 2020. EBITDA margin stood at 15.7% in Q2 September 2021 lower than 16% in Q2 September 2020. EBITDA for Q2 FY2022 includes an adverse impact of about 80 bps for one-time costs related to US specialty restructuring.

    Manufacturing and other expenses were 28.5% of sales at Rs 1142.50 crore compared to Rs 1030.90 crore in Q1 FY2022.

    During the quarter, the company booked a provision of Rs 1879.60 crore [including Rs 38.7 crore towards litigation and settlement related expenses] under Glumetza class actions towards business compensation expense based on the agreement to settle the dispute with two plaintiff groups as well as Impairment expense of Rs 707.7 crore for Solosec IP.

    Lupin's North America sales for Q2 FY2022 were at Rs 1429.10 crore, up 7.2% compared to Q1FY2022. It accounted for 36% of Lupin's global sales.

    Lupin's India formulation sales for Q2 FY2022 were Rs 1543.50 crore, down 5.7% as compared to Q1 FY2022. It accounted for 38% of Lupin's global sales

    Lupin's Europe, Middle-East and Africa sales saw a 33.3% rise, contributing 9% of the total revenue.

    Lupin's Global API sales for Q2 FY2022 were Rs 2,67.80 crore, up 8.9% compared to Rs 245.90 crore in Q1 FY2022, accounting for 7% of Lupin's global sales.

    Investment in R&D amounted to Rs 330 crore (8.2% of sales) for Q2 FY2022 as compared to Rs 373.70 crore (8.8% of sales) for Q1 FY2022.

    Lupin received approval for 1 ANDA from the USFDA in the quarter. Cumulative ANDA filings with the USFDA stand at 444 as of 30 September 2021, with the company having received 292 approvals to date.

    Lupin is an innovation-led transnational pharmaceutical company. The company develops and commercializes a wide range of branded and generic formulations, biotechnology products and APIs in over 100 markets in the U.S., India, South Africa and across Asia Pacific (APAC), Latin America (LATAM), Europe and Middle-East regions.

    Shares of Lupin were down 1.22% at Rs 925.40.

    Back to news list
Previous Stories :
More
Hot Pursuit News

Quick Links

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
91-22-25229720
91-22-25230011
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 26-Nov-2021
  •  ( 15:42) Sensex crashes 1,700 pts; The Nifty index manages to close above 17,000  
  •  ( 14:39) Indices hover near intraday low; The Nifty index holds 17,100 level  
  •  ( 12:32) LIC of India picks up minor stake in Aurobindo Pharma on Nov. 24  
  •  ( 12:20) Kirloskar Ferrous to acquire a majority stake in ISMT  
  •  ( 12:07) Shreyas Shipping & Logistics purchases carrier TBC Kailash for $14.60 mil.  
  •  ( 11:50) Indian Metals board OKs 1:1 bonus issue  
  •  ( 11:37) Indices hit intraday low; market breadth remains weak  
  •  ( 11:00) Ramkrishna Forgings bags order worth $1.2 mn in Oil & Gas segment  
  •  ( 10:35) The Nifty index trades below 17,200 level  
  •  ( 10:34) Benchmarks edge lower as COVID-19 fears re-escalate  
  •  ( 10:16) Tarsons Products lists at Rs 700 vs issue price of Rs 662  
  •  ( 10:14) Greenlam Ind board to mull stock split on 13 Dec  
  •  ( 09:32) Domestic indices open lower; The Nifty index trades beneath 17,300 mark  
  •  ( 08:46) Godrej Properties acquires land parcel in Bengaluru's Sarjapur  
  •  ( 08:35) Asian stocks trading lower  
Show News
26 November 2021 00:00
3143.90
(0.01 %)
661.80
(-2.68 %)
3333.95
(-1.66 %)
6803.75
(-4.60 %)
16679.95
(-3.88 %)
737.45
(-3.60 %)
4744.90
(3.32 %)
2742.10
(-4.49 %)
1107.75
(-1.53 %)
1490.10
(-2.24 %)
2334.75
(-0.64 %)
721.95
(-3.86 %)
901.45
(-6.01 %)
1690.45
(-1.86 %)
223.95
(-3.18 %)
1962.95
(-3.54 %)
1777.35
(-3.88 %)
852.90
(-4.27 %)
7170.90
(-5.27 %)
19210.35
(0.11 %)
128.65
(-4.84 %)
201.85
(-1.15 %)
2412.15
(-3.30 %)
470.50
(-4.09 %)
766.35
(-2.03 %)
1112.25
(-5.23 %)
3445.65
(0.00 %)
1520.40
(-2.46 %)
2291.80
(-4.43 %)
7390.65
(-2.88 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.